Literature DB >> 22117034

Anatomical factors involved in difficult cardiac resynchronization therapy procedure: a non-invasive study using dual-source 64-multi-slice computed tomography.

Antoine Da Costa1, Alexie Gate-Martinet, Pierre Rouffiange, Alexis Cerisier, Abdallah Nadrouss, Laurence Bisch, Cécile Romeyer-Bouchard, Karl Isaaz.   

Abstract

AIMS: In cardiac resynchronization therapy (CRT) procedure, left ventricular (LV) lead implantation is time consuming. In this clinical setting, no study has investigated the impact of right atrium anatomical parameters on both CRT implantation procedure duration and X-ray exposure. Additionally, only few studies have examined the coronary sinus (CS) using dual-source 64-multi-slice computed tomography (DS 64-MSCT), and its impact on CRT procedure parameters has not yet been investigated. The aim of this prospective study was to identify local anatomical predictive factors of difficult CRT implantation procedure using DS 64-MSCT. METHODS AND
RESULTS: Between January and July 2010, 50 consecutive patients underwent primo CRT implantation. The patient population had a mean age of 70 ± 10 years, and was 34% female, with New York Heart Association Class 3.2 ± 0.3 heart failure, left ventricle ejection fraction 30 ± 4%, and QRS width 157 ± 30 ms. Cardiac resynchronization therapy implantation was attempted in 50 patients, and first LV lead implantation was obtained in 49 of 50 patients (98% primary success). One implantation failed (2%) due to unsuccessful LV lead implant. Procedure parameters were as follows: LV threshold, 1.4 ± 0.8 V; LV wave amplitude, 17 ± 8 mV; LV impedance, 830 ± 240 Ω; median procedure time (skin to skin), 51 min (38 min); median fluoroscopy procedure time, 11.9 min (22 min); and median LV fluoroscopic time, 10.3 min (22 min). In 10 patients (20%), procedures were difficult requiring an implantation lasting ≥ 85 min. The only predictive factor for difficult CRT implantation was the insertion level of the CS ostium (CSO), evaluated by the distance between the CSO and the bottom floor of the right atrium (14.8 ± 4 vs. 9.5 ± 4; P= 0.01). Neither the right atrium dilation nor right ventricular dysfunction was associated with difficult CRT implantation procedures.
CONCLUSIONS: Today, despite improvements in the materials used, problems still remain in the CRT procedure. In this clinical setting, the only predictive factor for very long CRT procedures is the CSO-level insertion (located high). This anatomical anomaly identified by DS 64-MSCT prior to surgery is responsible for 20% of difficult CRT device implantation procedures.

Entities:  

Mesh:

Year:  2011        PMID: 22117034     DOI: 10.1093/europace/eur350

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  MicroRNAs Association in the Cardiac Hypertrophy Secondary to Complex Congenital Heart Disease in Children.

Authors:  Ma C Sánchez-Gómez; K A García-Mejía; M Pérez-Díaz Conti; G Díaz-Rosas; I Palma-Lara; R Sánchez-Urbina; M Klünder-Klünder; J A Botello-Flores; N A Balderrábano-Saucedo; A Contreras-Ramos
Journal:  Pediatr Cardiol       Date:  2017-04-05       Impact factor: 1.655

2.  Extracardiac compression of the inferolateral branch of the coronary vein by the descending aorta in a patient with dilated cardiomyopathy.

Authors:  Hiroki Konishi; Shumpei Mori; Tatsuya Nishii; Yu Izawa; Naoki Tamada; Hidekazu Tanaka; Kunihiko Kiuchi; Koji Fukuzawa; Ken-Ichi Hirata
Journal:  J Arrhythm       Date:  2017-10-11

3.  Coronary Sinus Phlebography in Cardiac Resynchronization Therapy Patients: Identifying and Solving Demanding Cases.

Authors:  Lenine Angelo Alves Silva; Enoch Brandão de Souza Meira; Jefferson Curimbaba; João A Pimenta
Journal:  J Innov Card Rhythm Manag       Date:  2020-07-15

4.  A left ventricular lead implantation at the latest site based on four-dimensional computed tomography: a case report.

Authors:  Akinori Matsumoto; Ryo Ogawa; Masafumi Maeda; Aya Inakami
Journal:  Eur Heart J Case Rep       Date:  2020-02-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.